Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON).
EGF-R expression was found to be increased in 40% of malignant epithelial ovarian neoplasms by an immunohistochemical method. No correlation was found between EGF-R expression and clinical stage. There was a suggestion of reduced survival among tumours with positive EGF-R expression.